


LALACA 75 လာလာကာ
-
Pregabalin 75 mg ပရီဂါဘာလင် ၇၅ မီလီဂရမ်
-
Pregabalin 75 mg for Neuropathic Pain Pregabalin 75 mg (Neuropathic Pain Reliever)
Country of Origin: Korea Manufactured by: Yoo Young Pharmaceutical
Imported and Distributed by: Tri Care Co., Ltd LALACA 75 can be used for Diabetic Peripheral Neuropathy Post-herpetic Neuralgia Low Back Pain with Radiculopathy Other Neuropathic Pain Spinal Cord Injury Fibromyalgia Epilepsy or Seizure Generalize Anxiety Disorder Post-operative Pain ဆီးချိုကြောင့် အာရုံကြောများထိခိုက်ပျက်စီးသောရောဂါ ရေယုန်ပေါက်ပြီးနောက် အာရုံကြော နာကျင်ခြင်း အာရုံကြောညှပ်ခြင်းကြောင့် ခါးနာခြင်း အခြားအာရုံကြောထိခိုက်မှုများကြောင့် နာကျင်ခြင်း ကျောရိုးမကြီး
ထိခိုက်မိခြင်း ကြွက်သားထုံ၍ နာကျင်ကိုက်ခဲခြင်း အတက်ရောဂါများ စိုးရိမ်သောကများသောရောဂါ ခွဲစိတ်ပြီးလူနာများတွင် အနာသက်သာစေရန်အတွက်လည်း
အသုံးပြုကြပါသည်။
10 X 10 Capsules 10 X 10 Capsules
Adult Dosage Management of
neuropathic pain associated with diabetic
peripheral neuropathy: § Recommended
maximum therapeutic dosage is 300 mg/d § Suggested
starting dosage is 50 mg 3 times daily § Dosage
can increase to 300 mg/d within 1 week of starting treatment. Management
of neuropathic pain associated with spinal cord injury § Recommended
therapeutic dosage is 150 mg to 600 mg daily § Recommended
starting dosage is 75 mg twice daily § Dosage
may be increased to 150 mg twice daily within 1 week of initiating
treatment § Patients
with suboptimal pain relief following 2 to 3 weeks of treatment with 150 mg
twice daily may be increased up to 300 mg twice daily § In
spinal cord injury, pain improvement can be seen as early as 1 week after
initiating treatment § However,
to evaluate the efficacy of pregabalin, it is recommended that the medication
be tried for 4 to 6 weeks if the patient tolerates it. Management
of postherpetic neuralgia § Recommended
therapeutic dosage is 150 mg to 300 mg daily, divided into dosing twice or
thrice daily § Recommended
starting dosage is 75 mg twice daily or 50 mg thrice daily § Dosage
can be increased to 300 mg daily within 1 week of starting treatment § After
2 to 4 weeks of treatment with 300 mg daily, patients with suboptimal pain
relief can be increased to 600 mg, divided into twice daily or thrice daily. Management
of fibromyalgia § Recommended
therapeutic dosage is 300 mg to 450 mg daily § Recommended
initial dosage is 150 mg/d, divided into twice-daily doses § Dosage
can be increased to 300 mg daily within 1 week of starting treatment § Patients
with suboptimal pain relief on 300 mg daily may further increase to 450 mg
daily, divided into twice-daily dosing. Adjunctive therapy for adults with partial onset
seizures Pregabalin is
FDA-approved only as an adjunctive for treating partial-onset seizures § Effective
dosage is 150 mg to 600 mg daily, divided twice or thrice-daily dosing § Suggested
starting dosage is no greater than 150 mg daily, and the total dosage can
increase to 600 mg daily. Generalized anxiety disorder § Initial
dosage is 75 mg daily, which may increase by 75 mg during the first week of
treatment maximum dosage can be up to 300 mg thrice daily. Social anxiety disorder § Initial dosage is
100 mg thrice daily, which may increase by 150 mg daily over 1 week § Dosage
may increase to 600 mg daily based on response and tolerability.